(Q74371912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Graft-versus-host reactions in dermatology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M L Johnson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E R Farmer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

369-92; quiz 393-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

Indications for Marrow Transplantation

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Immunological reconstitution of sex-linked lymphopenic immunological deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

A compendium of reported human bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

The major histocompatibility complex--genetics and biology. (First of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

The major histocompatibility complex - genetics and biology (third of three parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Advances in human leukocyte antigens and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

A randomized study of the prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

XX-XY lymphoid chimaerism in congenital immunological deficiency syndrome with thymic alymphoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Cytogenetic evidence concerning possible transplacental transfer of leukocytes in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Irradiation of blood products. Indications and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-vs.-host disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Transfusion-associated graft-versus-host disease and the irradiation of blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Is chronic graft versus host disease an autoimmune disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Acute cutaneous eruptions after marrow ablation: roses by other names?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Induced autologous graft-versus-host disease for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Roquinimex-induced graft-versus-host reaction after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Possible Graft-versus-Host Reaction after Intrauterine Transfusion for Rh Erythroblastosis Fetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Marrow transplantation from related donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

The major histocompatibility complex--genetics and biology (second of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease in dog and man: the Seattle experience

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Marrow grafts between DL-A-matched canine littermates

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Cytokine dysregulation as a mechanism of graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

T-lymphocyte-antigen interactions in transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Current thoughts on the pathogenesis of graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Human minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease in bone marrow transplantation: experimental, laboratory, and clinical contributions of the last few years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Role of natural killer cells in the pathogenesis of human acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Identification of Natural Killer (NK) Cells in Lesions of Human Cutaneous Graft-Versus-Host Disease: Expression of a Novel NK-Associated Surface Antigen (Kp43) in Mononuclear Infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Prevention of murine graft-versus-host disease by inducing and eliminating ASGM1+ cells of donor origin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Natural killer cells and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Mast cell depletion in murine chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Cytotoxic antibody for epithelial cells in human graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Immunoglobulins and Complement in Skin in Graft-Versus-Host Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Skin antibodies in bone marrow transplanted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Ontogeny of human epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

The loss of Ia+ Langerhans' cells during graft-versus-host disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Cutaneous immunological studies in diagnosis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-Versus-Host Disease: Pathophysiological and Clinical Aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Intestinal and hepatic complications of human bone marrow transplantation. Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Cutaneous eruptions of lymphocyte recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Sclerodermatous graft-versus-host disease limited to an area of measles exanthem

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Graft-versus-host disease limited to area of irradiated skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Immunotoxins for the therapy of graft versus host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Thalidomide in the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Autologous peripheral blood progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Applications of extracorporeal photochemotherapy in "non-oncological" diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970495-5

7 January 2021

10.1016/S0190-9622(98)70495-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9520019%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference